SolarEdges, Next

SolarEdge's Next Act Rests on Cost Cuts, Not the Quarter It Just Reported

Published on 11/06/2026 at 03:30 | Editorial boerse-global.de
SolarEdge shares slid 13% after weak Q4 guidance and soft US and Germany demand; Susquehanna trimmed its target to $31 and kept a Neutral rating.
SolarEdge's Next Act Rests on Cost Cuts, Not the Quarter It Just Reported Illustration mit AI erstellt.

SolarEdge's latest earnings release landed with a thud, and the stock's 13% one-day slide on Thursday tells you most of what you need to know about how investors read it. The headline number wasn't the problem. The problem was what management said about the months ahead.

For the third quarter of 2026, the company posted revenue of $326.1 million, down 4.1% from a year earlier. On the surface, the GAAP gross margin of 33.2% looks sturdy enough. Dig into the fine print, though, and $36.0 million of that figure traces to a favorable effect tied to IEEPA tariff matters. Strip that out and the picture changes considerably — which is precisely why the forward guidance carries more weight than the backward-looking result.

A Margin That Flatters, a Forecast That Doesn't

Management's outlook for the fourth quarter of 2026 calls for an adjusted gross margin of 17% to 21%, a non-GAAP measure. Set beside the reported 33.2%, the gap is stark, and it underscores how much of the recent profitability rested on a one-off tailwind rather than underlying operations. Adjusted operating expenses are expected to come in at no less than $87 million.

Revenue for the closing quarter is guided to a range of $245 million to $275 million. Against that cost base, the top line leaves little room for error. Weak demand, in other words, has a direct line to the bottom line.

Should investors sell immediately? Or is it worth buying SolarEdge?

The demand story itself is not complicated. SolarEdge's management flagged soft conditions in the United States and further deterioration in Germany. Those are two of the company's most important markets, and neither is offering much encouragement right now.

Susquehanna Trims Its Target, Keeps Its Distance

Susquehanna lowered its price target on the stock from $32 to $31, maintaining a Neutral rating. The firm's reasoning centers on a quarterly forecast that came in roughly 20% below expectations. Higher interest rates and headwinds in tax-structured financing in the US were cited as drags, alongside the planned reduction of Germany's feed-in tariff, which is weighing on European demand.

Other analysts also cut their targets, so Susquehanna is hardly alone in rethinking the valuation. But the confirmed Neutral stance is telling in its own right: a lower target does not, in this case, translate into a buying opportunity.

The cautious view extends beyond the current quarter. Susquehanna sees a substantial gap between management's framework and the analyst consensus for the following year as well. That shifts the focus to a harder question — how effectively SolarEdge can resize its cost base for a smaller business.

The 2027 Blueprint: Breakeven, Not Growth

Management's plan for 2027 envisions largely flat revenue and adjusted EBITDA around the breakeven line. According to Susquehanna, that revenue framework sits roughly $150 million below consensus. A return to robust growth is not part of the company's own planning.

Restructuring and exits from selected markets are meant to bridge the gap. The trade-off is plain: those moves lighten the cost base while shrinking the revenue opportunity. Savings from the restructuring are expected to reach the mid-single-digit millions of dollars per quarter starting in the first quarter of 2027. The market exits, meanwhile, carry an associated annual revenue headwind of $40–50 million.

SolarEdge at a turning point? This analysis reveals what investors need to know now.

Whether the savings outrun the lost sales is the crux of the investment case from here.

Data Centers: A 2028 Story, Not a 2026 Fix

SolarEdge is pointing to its SST technology for AI data centers as a longer-term growth driver, and it does open a genuine additional avenue. It just doesn't substitute for an imminent recovery in the existing business. Pilot projects are slated for 2027, with volume shipments planned from 2028 — a timeline that cleanly separates the product opportunity from the demand problems of the moment.

Read together, the target cut and the guidance amount to a more cautious appraisal of the business rather than a verdict on any single quarter. Cost discipline is supposed to carry SolarEdge to breakeven while newer applications mature. The Neutral rating fits that in-between phase: long-term promise on one side, soft demand and reduced revenue expectations on the other. For now, the burden of proof sits squarely on the company's ability to deliver a durable operating recovery — one that doesn't depend on a tariff-related boost to look convincing.

Ad

SolarEdge Stock: New Analysis - 6 November

Fresh SolarEdge information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated SolarEdge analysis...

Disclaimer...
en | US83417M1045 | SOLAREDGES | boerse | 70467214 |